AAOS approaches “Next to Normal” as surgeons and industry focus on solutions to meet the needs of patients returning to joint replacement
If an ad agency had branded the American Academy of Orthopedic Surgeons (AAOS) 2023 Annual Meeting this year, the tagline would have read “Getting back to normal.” Surgeons toured the exhibit hall throughout the day not just during dedicated hours. The meeting felt as if it had come back to life with industry symposiums and conference presentations often seeing standing-room-only crowds when a few years ago even the exhibit floor felt like a ghost town. And while some of the large orthopedic companies slightly scaled down their booth space, several mid-tier and small market players increased their presence at the meeting in an attempt to pique surgeon interest. So what was the buzz at AAOS 2023 related to hip and knee replacement? In this article, SmartTRAK outlines some of the key takeaways, including:
- Procedure Recovery May Signal Return of Deferred Procedures
- Both clinicians and company representatives at the meeting revealed to SmartTRAK that they are seeing increased hip and knee procedure volumes heading into 2023. The overall consensus was ...
- Both clinicians and company representatives at the meeting revealed to SmartTRAK that they are seeing increased hip and knee procedure volumes heading into 2023. The overall consensus was ...
- The Move to Outpatient Joint Replacement Continues.
- Data presented at AAOS 2023 continues to support the move of joint replacement surgeries to an outpatient setting. A study focusing on patient satisfaction after outpatient joint replacement in an academic medical center reported ...
- Data presented at AAOS 2023 continues to support the move of joint replacement surgeries to an outpatient setting. A study focusing on patient satisfaction after outpatient joint replacement in an academic medical center reported ...
- Cementless Knee Trend Growing Despite Mixed Results
- Clinical evidence presented at AAOS showed mixed results for cementless total knees with some studies reporting excellent outcomes and others identifying increased risks associated with ...
- Clinical evidence presented at AAOS showed mixed results for cementless total knees with some studies reporting excellent outcomes and others identifying increased risks associated with ...
- Assistive Technologies Growing and Evolving
- Assistive technology presentations and booth exhibits seemed to generate the most interest at AAOS 2023. Elise Wolf, SmartTRAK’s assistive technologies expert, noted the most innovative products and ...
- Assistive technology presentations and booth exhibits seemed to generate the most interest at AAOS 2023. Elise Wolf, SmartTRAK’s assistive technologies expert, noted the most innovative products and ...
To download and read the complete "AAOS 2023: Total Joint Viewpoint" article by SmartTRAK's Lisa Mahan, VP Product Development & IT, Sr. Analyst TJ&E, just click the button below.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.